TherapeuticsMD, Inc. (TXMD) › Gross ProfitTherapeuticsMD, Inc. (TXMD) — Gross ProfitAnnual figures by fiscal year, from SEC filings.2011: $1.14M2012: $2.47M2013: $6.82M2014: $11.35M2015: $15.64M2016: $15.17M2017: $14.14M2018: $13.36M2019: $43.31M2020: $48.90M2021: $1.17M2022: $68.57M2023: $1.30M$1.30M2011Gross Profit (USD)2023Fiscal YearGross ProfitChange YoY2023$1.30M-98.1%2022$68.57M+5755.3%2021$1.17M-97.6%2020$48.90M+12.9%2019$43.31M+224.1%2018$13.36M-5.5%2017$14.14M-6.8%2016$15.17M-3.0%2015$15.64M+37.7%2014$11.35M+66.6%2013$6.82M+176.0%2012$2.47M+116.5%2011$1.14M—Other metrics: RevenueCost of RevenueOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share